You are here: Industry Insights > Roche

News List

French authority orders €444m fine on Novartis, Roche over Lucentis pharmaceutical-technology
September 24, 2020
The French competition authority has imposed a total fine of €444m on Novartis, Roche and Genentech for allegedly following abusive practices to push more sales of eye disease drug Lucentis than a cheaper drug.
Roche acquires biotech firm Inflazome for $449m pharmaceutical-technology
September 22, 2020
Roche has completed a share purchase agreement to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m).
Roche gets positive CHMP opinion for Tecentriq plus Avastin to treat liver cancer expresspharma
September 21, 2020
The recommendation from the CHMP is based on results from the Phase III IMbrave150 study, which showed that Tecentriq in combination with Avastin reduced the risk of disease worsening or death.
Roche’s Genentech gets US FDA approval for Gavreto (pralsetinib) expresspharma
September 07, 2020
The drug is used to treat metastatic RET fusion-positive non-small cell lung cancer.
Roche to launch SARS-CoV-2 rapid antigen test pharmatimes
September 03, 2020
Roche is gearing up to launch an antigen test able to “reliably and quickly” triage people suspected of SARS-CoV-2, with results available in just 15 minutes.
US approves Roche's new pan-tumour liquid biopsy test pharmatimes
August 28, 2020
US regulators have approved Roche's new pan-tumour liquid biopsy test for patients with solid tumours, offering a potentially more convenient option and an alternative for patients unable to have tissue biopsy.
PTC Therapeutics Achieves $20M Roche Milestone contractpharma
August 28, 2020
Payment was triggered by the first commercial sale of Evrysdi in the U.S. which was approved by the FDA on August 7 to treat SMA.
Roche teams up with Regeneron on Covid-19 therapy pharmaceutical-technology
August 21, 2020
Roche has partnered with Regeneron Pharmaceuticals to develop, manufacture and distribute the latter’s antiviral antibody combination, REGN-COV2, as a potential treatment of Covid-19.
EMA accepts marketing application for Spinal Muscular Atrophy treatment europeanpharmaceuticalreview
August 20, 2020
The European Medicines Agency (EMA) has accepted the marketing authorisation application for Evrysdi™ (risdiplam) as a treatment of spinal muscular atrophy (SMA).
Roche, Regeneron Partner to Increase Global Supply of REGN-COV2 contractpharma
August 20, 2020
To develop, manufacture and distribute REGN-COV2, Regeneron’s investigational antiviral antibody combination to treat COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page